SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

EVAA Protocol

EVAA Protocol ($EVAA) is trending as community members discuss recent price movements and potential shorting opportunities based on technical analysis. Some users are pointing to potential risks, with discussions around possible scams, while others highlight its performance within the TON ecosystem.

DTE Energy Co. operates as a diversified energy company, which engages in the development and management of energy-related businesses and services. It operates through the following segments: Electric, Gas, DTE Vantage, Energy Trading, and Corporate and Other. The Electric segment consists of generation, purchase, distribution, and sale of electricity to residential, commercial, and industrial customers in southeastern Michigan. The Gas segment is involved in the purchase, storage, transportation, distribution, and sale of natural gas to residential, commercial, and industrial customers throughout Michigan, and the sale of storage and transportation capacity. The DTE Vantage segment focuses on projects that deliver energy and utility-type products and services to industrial, commercial, and institutional customers, produce reduced emissions fuel, and sell electricity and pipeline-quality gas from renewable energy projects. The Energy Trading segment covers energy marketing and trading operations. The Corporate and Other segment includes various holding company activities, holds certain non-utility debt, and holds certain investments, as well as funds supporting regional development and economic growth. The company was founded in January 1995 and is headquartered in Detroit, MI.

DTE Energy Co.

DTE Energy is trending due to a mix of factors, including analyst rating adjustments and discussions around the company's investments in clean energy and infrastructure. The community is focused on the balance between growth initiatives, debt, and potential risks, while also noting the hyperscale data center agreement and potential for increased energy demand.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending due to a significant price surge, sparking debates about its potential as 'the new Bitcoin' and the impact of its privacy features. Community members are actively discussing entry and exit strategies amidst the volatility, while also comparing it to other cryptocurrencies.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

DAVE is trending due to a Department of Justice lawsuit alleging deceptive practices, with potential consumer redress exceeding $200 million, sparking concerns about the company's future. Despite this legal challenge, some community members remain optimistic, pointing to upcoming BNPL initiatives and strong Q3 2025 adjusted EBITDA margins. Recent analyst target price increases add to the mixed sentiment surrounding the stock.

Spark is an onchain capital allocator, with $3.86B deployed across DeFi, CeFi, and RWA. It unlocks capital efficiency at scale, auto-balancing allocations based on market conditions while maintaining a conservative risk profile. Spark was created to solve DeFi’s core inefficiencies: fragmented liquidity, unstable yields, and idle stablecoin capital. It acts as a two-sided capital allocator—borrowing from Sky’s $6.5B+ reserves and deploying across DeFi, CeFi, and RWAs to provide deep, consistent liquidity. This yield is packaged into products like sUSDS and sUSDC, offering users programmable, fee-free income. Rather than competing with protocols, Spark powers them as the liquidity and yield infrastructure for onchain finance.  Access to Deep, Scalable Liquidity: Spark taps into Sky’s $6.5B+ stablecoin reserves, enabling large-scale capital deployment across DeFi, CeFi, and RWAs. User-Friendly Yield Products: Yield is delivered through stablecoins like sUSDS and sUSDC—fully composable, fee-free, and available across chains.  SparkLend: A stablecoin lending market. Unlike other lending protocols where rates fluctuate based on utilization or loan size, SparkLend offers governance-defined rates that do not vary based on those factors. This is made possible by Spark’s Liquidity Layer (SLL), which supplies consistent stablecoin liquidity to the protocol.  Spark Savings: A product for earning yield on stablecoins like USDC, and USDS (and soon, USDT) by converting them into yield-bearing sUSDS or sUSDC. These yield tokens are composable with other DeFi protocols, making it easy to put capital to work while maintaining exposure to onchain yield at a competitive risk-adjusted rate.  Spark Liquidity Layer (SLL): A backend capital allocator that routes liquidity to other protocols like Aave, Morpho, and even RWAs (e.g., BlackRock’s BUIDL). One of the most important SLL deployments on Base is the Spark USDC Morpho Vault, which currently supplies $95M USDC, making it the largest liquidity provider to the Coinbase app integration on Base. This vault plays a key role in mitigating rate volatility for borrowers and demonstrates how SLL enhances liquidity conditions across DeFi.  Existing Products: Spark's total TVL is currently $7.9B, split between SparkLend and the Spark Liquidity Layer (SLL). You can find real-time details and breakdowns here: https://defillama.com/protocol/spark#information  Spark in DeFiLlama, https://defillama.com/protocol/spark#information  SparkLend is one of the largest lending protocols in DeFi. It offers deep liquidity and governance-defined rates, providing borrowers with transparent conditions.  Spark Savings is live on Ethereum mainnet, Base, Optimism, Arbitrum, Unichain, and Gnosis, offering vaults for both USDS and USDC.  The Spark Liquidity Layer actively deploys capital across protocols on multiple chains, including Ethereum mainnet, Base, and Arbitrum.  SLL allocations in real-time, https://data.spark.fi/spark-liquidity-layer

Spark

Spark (SPK) is trending as community members discuss its potential for a breakout, pointing to recent news and a roadmap including SparkLend expansions and Savings V2. Speculation is fueled by its low market cap, recent positive price movement, and high trading volume, with some anticipating a retest of previous highs and others suggesting it's oversold.

MBIA, Inc. is a holding company, which engages in the provision of financial guarantee insurance, related reinsurance, advisory and portfolio services, and asset management advisory services. It operates through the following business segments: U.S. Public Finance Insurance, Corporate, and International and Structured Finance Insurance. The U.S. Public Finance Insurance segment issues financial guarantees for municipal bonds, including tax-exempt and taxable indebtedness of U.S. political subdivisions through its National subsidiary. The Corporate segment consists of general corporate activities including providing general support services to MBIA's other operating businesses and asset and capital management. The International and Structured Finance Insurance segment includes the operation of MBIA Corp. The company was founded in 1973 and is headquartered in Purchase, NY.

MBIA Inc.

MBI is trending due to its announcement of a special $8 per share dividend, sparking discussions around the stock's potential price movement and the implications for shareholders. The community is weighing the opportunity to capture the dividend against concerns about a potential price drop post-payout, with some speculating about a potential acquisition by $AGO given its current financial state and PREPA claims.

CoreCivic, Inc. operates as a government solutions company, which engages in the development and management of prisons and other correctional facilities. It operates through the following segments: Safety, Community, and Properties. The Safety segment consists of correctional and detention facilities. It provides transportation services to government agencies and TransCoR. The Community segment offers residential reentry centers and provides electronic monitoring case management services. The Properties segment consists of real estate properties owned by the company that are leased to government agencies. The company was founded by Thomas W. Beasley, T. Don Hutto, and Robert Crants on January 28, 1983 and is headquartered in Brentwood, TN.

CoreCivic Inc

CoreCivic ($CXW) is trending amid positive analyst updates, solid earnings reports, and discussion around government contracts. The community is focused on the potential for increased demand for CoreCivic's services, especially related to immigration policy shifts. Some are drawing comparisons to sector peer GEO Group and speculating about potential acquisitions.

Ingersoll Rand Inc. engages in the provision of services and solutions through air, fluid, energy, and medical technologies. It operates through the Industrial Technologies and Services, and Precision and Science Technologies segments. The Industrial Technologies and Services segment provides compressor, vacuum, blower solutions, and industrial technologies such as power tools and lifting equipment. The Precision and Science Technologies segment includes fluid management solutions such as precision liquid and gas pumps, and niche compression technologies. The company was founded in 1872 and is headquartered in Davidson, NC.

Ingersoll-Rand Inc

Ingersoll Rand is trending as the community analyzes recent earnings, revenue beats, and updated guidance, while considering mixed analyst ratings. Discussions include the impact of acquisitions and organic growth on the company's financial outlook. Option flow and unusual options activity are also being closely monitored, sparking speculation about potential market movements.

Rollins, Inc. is an international services company, which engages in the provision of pest and termite control services. Its service offerings include Residential, Commercial, and Termite. The company was founded by John W. Rollins Jr. and O. Wayne Rollins Sr. in 1948 and is headquartered in Atlanta, GA.

Rollins, Inc.

Rollins is trending due to positive earnings reports and analysts adjusting their ratings, with some citing the company's strong revenue growth and potential for continued gains. The community is also discussing insider selling activity and the company's recent appointment of a new CFO. Rollins' potential acquisition of other companies in the pest control space is also being considered.

This first memecoin ever created completely by AI.

Turbo Toad Token

Turbo Toad Token ($TURBO) is gaining traction as the community anticipates potential listings on major exchanges like Robinhood and discusses bullish technical indicators, including cup and handle formations. Some traders are expressing excitement about potential gains and comparing it to other meme coins, while others urge patience. Discussions also revolve around potential price targets for this cycle, with community members suggesting possible moves towards higher valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Y Intercept Hong Kong Ltd Takes $475,000 Position in Trevi Therapeutics, Inc. $TRVI

Y Intercept Hong Kong Ltd acquired a new position in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities...

Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025

Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a...

Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference

Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference PR Newswire NEW HAVEN, Conn., Nov. 4, 2025 Fireside Chat...

Wall Street Analysts Predict a 231.05% Upside in Trevi Therapeutics (TRVI): Here's  What You Should Know

The mean of analysts' price targets for Trevi Therapeutics (TRVI) points to a 231.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?

Trevi Therapeutics Completes Enrollment for Phase 2b CORAL Trial of Haduvio in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough

Trevi Therapeutics Completes Enrollment for Phase 2b CORAL Trial of Haduvio in Idiopathic Pulmonary Fibrosis Patients with Chronic Cough Trevi Therapeutics Completes Enrollment for Phase 2b CORAL...

Trevi Therapeutics to Participate in Upcoming February Investor Conferences

Trevi Therapeutics to Participate in Upcoming February Investor Conferences Trevi Therapeutics to Participate in Upcoming February Investor Conferences PR Newswire NEW HAVEN, Conn., Jan. 30, 2025 NEW...

Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

Trevi Therapeutics Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference Trevi Therapeutics Announces Company...

Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering

Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering PR Newswire NEW HAVEN, Conn., Dec. 16, 2024 NEW...

Shares of Trevi Therapeutics Inc. rose over 6% on Friday morning, building on momentum from the previous session when the stock hit over two-year intraday highs.&nbsp;The surge came as heavy retail buzz pushed the ticker to prominence on Stocktwits, where message volume spiked over 4,900% on Thursday.The company announced that its phase 2b study of Haduvio, an investigational therapy for idiopathic pulmonary fibrosis (IPF) with chronic cough, has achieved 75% of its enrollment target of 160 patients.&nbsp;An independent statistician confirmed the sample size following a re-estimation analysis, ensuring the trial’s design remains statistically robust.&nbsp;The analysis involved treating 80 patients with Haduvio’s highest dose (108 mg twice daily) over six weeks.Trevi reiterated that topline results are expected in the first half of 2025.Wall Street analysts responded positively to the update:•&nbsp;Jones Research reiterated a ‘Buy’ rating, stating the analysis enhances confidence in the trial’s statistical assumptions, which indicate a high likelihood of demonstrating significant cough reduction.• Needham’s Serge Belanger called the result the “best case outcome,” highlighting it as a de-risking event.&nbsp;He highlighted that&nbsp;the study’s treatment effect size and dropout rates align with initial assumptions, supporting the original design. Needham maintained a ‘Buy’ rating with an $8 price target.• H.C. Wainwright raised its price target to $7.50 from $6, describing the update as a “material positive” for investor sentiment ahead of data readouts.Year-to-date, TRVI stock has gained over 170%, as of the last close,&nbsp; showcasing strong investor interest in the company’s pipeline and prospects.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Retail Chatter For Trevi Therapeutics Soars After Enrollment Target For Chronic Cough Study Hits 75%

An independent statistician confirmed the sample size following a re-estimation analysis, ensuring that the trial’s design remains statistically robust.

Equity

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in 2011 and is headquartered in New Haven, CT.

Trevi Therapeutics Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.10	--	--	N/A
Q2 '25	-$0.10	-$0.09	13.60%	BEAT
Q1 '25	-$0.12	-$0.09	26.82%	BEAT
Q4 '24	-$0.13	-$0.11	14.18%	BEAT
Q3 '24	-$0.12	-$0.13	-8.75%	MISSED

TRVI
Trevi Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest TRVI News

TRVITrevi Therapeutics Inc